Sysmex Inostics, a pioneer in liquid biopsy diagnostics, birthed the field of circulating tumor DNA (ctDNA) testing over a decade ago. As a single-source partner, we offer clinical grade assays, such as SafeSEQ and the gold-standard OncoBEAM (BEAMing) digital PCR, to enable the highly sensitive detection of tumor molecular alterations from blood samples or other sample materials. Focused on global CRO testing & services, Patient testing in the US and CDx/IVD development, we support our pharma partners to provide their personalized cancer therapies and solutions on global markets.